05/03/2024
5:26 PM | Edgewise Therapeutics (Issuer)
KOCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:27 PM | Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:28 PM | Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:29 PM | Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:30 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:31 PM | Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/22/2024
7:07 AM | Edgewise Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
9:26 AM | Edgewise Therapeutics (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A | |
02/14/2024
7:43 AM | Deep Track Capital, LP (Filed by)
Edgewise Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
4:42 PM | Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
4:43 PM | Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
3:18 PM | Edgewise Therapeutics (Subject)
MOORE JOHN R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
4:28 PM | Edgewise Therapeutics (Subject)
Flynn James E (Filed by)
| Form SC 13G/A | |
01/29/2024
3:30 PM | Edgewise Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
01/23/2024
3:19 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024
3:54 PM | Edgewise Therapeutics (Filer)
| Form 424B5 | |
01/19/2024
7:44 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
5:02 AM | Edgewise Therapeutics (Filer)
| Form 424B3 | |
01/19/2024
5:04 AM | Edgewise Therapeutics (Filer)
| Form S-3MEF | |
01/19/2024
5:05 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
3:38 PM | Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:39 PM | Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:39 PM | Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
MOORE JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:39 PM | Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:39 PM | Edgewise Therapeutics (Issuer)
Fox Jonathan C (Reporting)
Fox Jonathan C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:22 PM | Edgewise Therapeutics (Subject)
MOORE JOHN R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
3:32 PM | Edgewise Therapeutics (Subject)
Russell Alan J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:05 AM | Edgewise Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/18/2023
6:12 PM | Edgewise Therapeutics (Issuer)
KOCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
6:13 PM | Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
6:13 PM | Edgewise Therapeutics (Issuer)
Semigran Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
6:13 PM | Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
6:13 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
6:13 PM | Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
6:13 PM | Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
7:01 AM | Edgewise Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/14/2023
3:05 PM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
3:17 PM | Edgewise Therapeutics (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13D/A | |
Gold Mania (Ad) Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential
He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite). See his free reveal right here. |
06/26/2023
3:28 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
8:57 PM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
3:08 PM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
6:29 PM | Brege Laura (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:29 PM | Edgewise Therapeutics (Issuer)
Edris Badreddin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:29 PM | Edgewise Therapeutics (Issuer)
ROOT JONATHAN D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:29 PM | Edgewise Therapeutics (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:30 PM | Edgewise Therapeutics (Issuer)
Fox Jonathan C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
7:01 AM | Edgewise Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
